Efficacy of N-163 strain of Aureobasidium pullulans-produced beta-glucan in improving muscle strength and function in patients with Duchenne muscular dystrophy; Results of a 6-month non-randomised open-label linear clinical trial
Raghavan, K.; Sivakumar, T.; Bharatidasan, S. S.; Srinivasan, S.; Dedeepiya, V. D.; Ikewaki, N.; Senthilkumar, R.; Preethy, S.; Abraham, S. J.
Show abstract
Duchenne muscular dystrophy (DMD) is a debilitating genetic disease that causes gradual muscle weakening and early mortality. After a 45-day clinical pilot study and a pre-clinical study in mdx mice demonstrating safety and efficacy, and anti-fibrotic and anti-inflammatory effects, respectively, of an Aureobasidium pullulans N-163 strain-produced B-1,3-1,6-glucan. We conducted this linear six-month clinical study to assess its efficacy. Twelve ambulatory and 12 non-ambulatory individuals with DMD were included; all received the N-163 strain of A.pullulans produed beta-glucan dietary supplement orally in addition to the standard treatment regimen, which included steroids. The Medical Research Council muscle score improved in 11 patients in the ambulatory group and in 8 patients in the non-ambulatory group. The six-minute walk test distance improved in nine patients, with a 29.5-meter average improvement. The North Star Ambulatory Assessment improved by 1 unit in three patients. This safe beta-glucan food supplement improved muscle function within 6 months. A comprehensive, multi-centric clinical research should be conducted for unravelling its potential as a disease-modifying drug adjuvant in DMD.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Creatine/creatinine ratio and myostatin as biomarkers to monitor muscle function in Duchenne Muscular Dystrophy patients 94%
- Duchenne muscular dystrophy patients lacking the dystrophin isoforms Dp140 and Dp71 and mouse models lacking Dp140 have a more severe motor phenotype 94%
- Cholesterol metabolism is a potential therapeutic target in Duchenne Muscular Dystrophy 93%
Similar papers in this journal
- High-resolution mass spectrometry-based non-targeted metabolomic discovery of disease and glucocorticoid biomarkers in an animal model of muscular dystrophy 93%
- The beneficial effect of chronic muscular exercise on muscle fragility is increased by Prox1 gene transfer in dystrophic mdx muscle 92%
- Investigating the impact of physical activity on mitochondrial function in Parkinson's disease (PARKEX): Study protocol for a randomised controlled clinical trial 92%
Similar papers in this journal
Similar papers in this journal
- Multipoint Stimulation Motor Unit Number Estimation of the Extensor Indicis and Anconeus after Cervical Spinal Cord Injury 90%
- The Impact of Brain-Derived Neurotrophic Factor rs6265 (Val66Met) Polymorphism on Therapeutic Electrical Stimulation for Peripheral Nerve Regeneration: A Preclinical Study of Therapy-Genotype Interactions 90%
- Feasibility of high-density surface electromyography for the detection of neuromuscular disorders in children 90%
Similar papers in this journal
- Enhanced expression of Dystrophin, IGF-1, CD44 and MYH3 in plasma and skeletal muscles including Diaphragm of mdx mice after oral administration of Neu REFIX Beta 1,3-1,6 glucan 95%
- Janus effect of glucocorticoids on differentiation of muscle fibro/adipogenic progenitors 92%
- Immediate effect of osteopathic techniques on human resting muscle tone in healthy subjects using myotonometry: A factorial randomized trial 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.